Pharmaceuticals

Rising Cancer Prevalence Driving Growth Of The Market Due To Aging Population And Growing Treatment Needs Is Supporting Development Across The Cancer Therapy Market

May 18, 2026May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Cancer Therapy Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The cancer therapy market size has witnessed rapid growth in recent years. It is forecast to expand from $210.44 billion in 2025 to $232.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. This historical growth can be attributed to an increase in cancer incidence, the adoption of chemotherapy, enhancements in hospital oncology infrastructure, the expansion of radiation therapy, and the aging population.

The cancer therapy market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $342.1 billion in 2030, achieving a compound annual growth rate (CAGR) of 10.1%. The expansion during the forecast period is attributable to advancements in biomarker-driven therapies, the development of the immuno-oncology pipeline, wider adoption of precision medicine, increasing healthcare expenditure, and earlier cancer detection. Significant trends expected during this period include the swift embrace of immunotherapy, the rise of targeted cancer treatments, the broadening of precision oncology, a greater reliance on combination therapies, and a transition towards individualized treatment protocols.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24492&type=smp

Which Strategic Drivers Are Supporting The Cancer Therapy Market Development?

The expanding occurrence of cancer is anticipated to drive the cancer therapy market’s growth in the coming years. Cancer defines a category of illnesses marked by the unrestrained proliferation and dissemination of abnormal cells throughout the body. The rise in cancer cases primarily stems from heightened exposure to environmental carcinogens such as air pollution and tobacco smoke. Cancer therapy is instrumental in managing this growing incidence by treating current patients, enhancing their survival rates, and mitigating disease progression. For instance, in February 2024, as reported by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, global cancer incidence is expected to reach over 35 million new cases by 2050, marking a 77% increase from the estimated 20 million cases recorded in 2022. Consequently, the increasing prevalence of cancer is a major force behind the cancer therapy market.

What Segment Types Are Included In The Cancer Therapy Market Analysis?

The cancer therapy market covered in this report is segmented –

1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types

2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types

3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers

Subsegments:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs

2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents

3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies

4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)

5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy

Which Trends Are Guiding The Development Of The Cancer Therapy Market?

Leading companies in the cancer therapy market are concentrating on developing advanced treatments, particularly immuno-oncology drugs, to improve treatment effectiveness by leveraging the body’s immune system to identify and eliminate cancer cells. Immuno-oncology drugs constitute a class of cancer treatments designed to stimulate or enhance the body’s own immune system, allowing it to more effectively recognize and attack cancerous cells. For example, in December 2024, Dr. Reddy’s Laboratories Ltd., an India-based pharmaceutical company, introduced Toripalimab, the first and only immuno-oncology medication sanctioned for the treatment of nasopharyngeal cancer, in India. This launch provides a new, targeted therapy option for patients affected by this rare and aggressive cancer, potentially leading to better outcomes through enhanced immune system interaction. The presence of toripalimab in India underscores Dr. Reddy’s commitment to expanding access to cutting-edge cancer therapies in regions that are currently underserved.

Which Companies Are Engaged In The Cancer Therapy Market Environment?

Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.

Access The Complete Cancer Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/cancer-therapy-global-market-report

Which Region Accounts For The Highest Share Of The Cancer Therapy Market?

North America was the largest region in the cancer therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cancer Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24492&type=smp

Browse Through More Reports Similar to the Global Cancer Therapy Market 2026, By The Business Research Company

Oncology Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report

Blood Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-drug-discovery-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795